SQNS (SQNS) Stock Price & Analysis

SQNS (SQNS) fell 7.06% to USD 3.29 as of June 10, 2026 at 10:41 UTC, according to Nexqual real-time market data.

SQNS last closed at USD 3.54; the session ranged USD 3.26–3.72 on volume of 256,340 shares. Market capitalization is $49.28M, with a 52-week range of USD 2.38–58.3 (NYQ). Source: Nexqual, June 10, 2026 at 10:41 UTC.

Key Statistics (as of June 10, 2026 at 10:41 UTC)

PriceUSD 3.29
Change▼ 7.06% (down)
Previous CloseUSD 3.54
OpenUSD 3.67
Day RangeUSD 3.26 – 3.72
52-Week RangeUSD 2.38 – 58.3
Volume256,340 shares
Market Cap$49.28M
ExchangeNYQ

Technical Analysis (SQNS)

Nexqual's technical model rates SQNS "NEUTRAL" based on 2 bullish and 3 bearish signals across 123 daily candles, as of June 10, 2026 at 10:41 UTC.

Overall SignalNEUTRAL
RSI (14)47.29 (neutral)
vs SMA50Below (USD 3.34)
MACD0.1 (positive)

Analyst Ratings (SQNS)

Wall Street analysts rate SQNS "Strong Buy" based on 4 analysts, with a mean price target of USD 11.25 (range USD 7–20), per Nexqual as of June 10, 2026 at 10:41 UTC.

Consensus RatingStrong Buy
Analyst Count4
Mean TargetUSD 11.25
High TargetUSD 20
Low TargetUSD 7
Buy / Hold / Sell4 / 0 / 0

Earnings (SQNS)

EPS EstimateUSD -0.47
Revenue Estimate$7.13M

Recent Earnings History

QuarterActual vs Estimate
2026-03-31USD -1.42 vs est -0.45 ▼ miss
2025-12-31USD -1.19 vs est -0.51 ▼ miss
2025-09-30USD -0.79 vs est -1.8 ▲ beat
2025-06-30USD -3.2 vs est -2.7 ▼ miss

Source: Nexqual, June 10, 2026 at 10:41 UTC.

Financials & Fundamentals (SQNS)

Total Revenue$24.32M
Revenue Growth (YoY)-24.80%
Gross Margin+46.06%
Operating Margin-156.64%
Profit Margin+0.00%
ROE-256.13%
Debt / Equity69.27
Current Ratio0.48
Total Cash$10.63M
Total Debt$50.41M
Free Cash Flow$-38.75M

Source: Nexqual, June 10, 2026 at 10:41 UTC.

Financial Health Score (SQNS)

Nexqual rates SQNS's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 10:41 UTC.

GrowthCritical — Revenue -26% YoY (annual), sharp decline
ProfitabilityCritical — Heavily loss-making — early-stage company
Balance SheetMixed — $11M cash vs $50M debt
Cash FlowWeak — FCF negative: -$39M, burning cash
EfficiencyCritical — ROE -256%, ROA -56.0%

Ownership (SQNS)

Insider Ownership+30.50%
Institutional Ownership+64.54%
Shares Outstanding14.98M
Float10.97M
Short % of Float+0.40%

Source: Nexqual, June 10, 2026 at 10:41 UTC.

Leadership (SQNS)

SQNS is led by Georges Karam (age 63), Chairman, CEO & President, per Nexqual as of June 10, 2026 at 10:41 UTC.

Chairman, CEO & PresidentGeorges Karam (age 63)
Chief Financial OfficerDeborah Choate (age 61)
Chief Technology OfficerQiuting Huang (age 67)
Executive Vice President of Worldwide SalesNikhil Taluja (age 53)
Executive Vice President of Product ManagementLouis Chuang (age 44)

Major Backers & Investors (SQNS)

Notable institutional backers of SQNS include Brc Group Holdings, Inc., Oasis Management Co Ltd., Dba Trading, LLC, according to Nexqual as of June 10, 2026 at 10:41 UTC.

Active Investors

InvestorStake
Brc Group Holdings, Inc.11.73%
Oasis Management Co Ltd.9.42%
Dba Trading, LLC9.35%
FMR, LLC9.24%
Hood River Capital Management LLC4.44%
Fidelity2.89%
Credit Industriel Et Commercial2.67%
Lynrock Lake LP1.78%

Source: Nexqual, June 10, 2026 at 10:41 UTC.

Peers & Related Stocks

SymbolNamePriceChange
GOCOGoHealth, Inc.USD 0.32▼ 52.52%
KRMDKORU Medical Systems, Inc.USD 4▲ 1.78%
PXLWPixelworks, Inc.USD 6.02▼ 5.79%
MXMagnachip Semiconductor CorporaUSD 6.28▼ 9.38%
GSITGSI Technology, Inc.USD 7.63▼ 4.74%

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 10:41 UTC. This page is informational and not investment advice.